VYGR
Voyager Therapeutics Inc
2.80$
-2.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
Voyager Therapeutics Inc (VYGR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -26 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -21 | -24 | 59 | -32 | -28 | -15 | -38 | -33 | -31 | -30 | -33 | -26 | -121 | |
| 0.9 | 1.3 | 1.2 | 1.4 | 1.1 | 1.0 | 1.0 | 1.1 | 0.9 | 1.0 | 0.6 | 0.9 | 3.5 | |
| 2.9 | 3.0 | 3.6 | 4.0 | 3.4 | 3.7 | 3.7 | 4.1 | 3.5 | 3.5 | 2.5 | 2.4 | 12 | |
| 2.8 | -83 | 66 | -26 | -22 | 17 | -12 | -3.1 | -6.9 | -6.9 | -9.8 | -7.9 | -32 | |
| 0.8 | 0.8 | 2.1 | 1.0 | 0.3 | 0.2 | 0.7 | 1.1 | 0.2 | 0.6 | 0.0 | 0.0 | 0.9 | |
| -158 | 27 | -96 | -36 | 64 | -27 | 41 | 1.9 | 35 | 47 | 8.1 | 15 | 106 | |
| – | – | 19 | – | – | – | – | 0.4 | – | – | – | – | – | |
| 0.3 | 0.5 | 113 | 0.6 | 0.0 | 0.6 | 0.1 | 0.5 | 0.1 | 0.1 | 3.3 | 2.9 | 6.5 | |
| -179 | 3.5 | 76 | -67 | 36 | -41 | 3.4 | -31 | 1.2 | 17 | -22 | -7.5 | -11 | |
| -22 | -25 | 57 | -33 | -28 | -15 | -39 | -34 | -31 | -31 | -33 | -26 | -121 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.